Melanoma risk up in IBD independent of biologic therapy

January 31, 2014
Melanoma risk up in IBD independent of biologic therapy

(HealthDay)—Inflammatory bowel disease (IBD) is associated with an increased risk of melanoma, independent of the use of biologic therapy, according to research published in the February issue of Clinical Gastroenterology and Hepatology.

Siddharth Singh, M.B.B.S., of the Mayo Clinic in Rochester, Minn., and colleagues conducted a of the literature and performed a meta-analysis of 12 cohort studies, involving a total of 172,837 with IBD, to assess the association between IBD and risk of .

The researchers found that IBD was associated with an increased risk of melanoma (12 studies: relative risk [RR], 1.37; 95 percent confidence interval [CI], 1.10 to 1.70). The risk of melanoma was increased in patients with Crohn's disease (seven studies: RR, 1.80; 95 percent CI, 1.17 to 2.75) and patients with ulcerative colitis (seven studies: RR, 1.23; 95 percent CI, 1.01 to 1.50). The risk of melanoma was higher in patients with IBD for studies performed prior to 1998, before biologic therapies were introduced (eight studies: RR, 1.52; 95 percent CI, 1.02 to 2.25), but not for studies performed after 1998 (two studies: RR, 1.08; 95 percent CI, 0.59 to 1.96).

"Based on a meta-analysis, IBD has been associated with an increased risk of melanoma, independent of the use of biologic therapy," the authors write. "Patients diagnosed with IBD should be counseled on their risk for melanoma."

Explore further: Inflammatory bowel disease raises risk of melanoma

More information: Abstract
Full Text
Editorial

Related Stories

Inflammatory bowel disease raises risk of melanoma

May 20, 2013

Patients with inflammatory bowel disease (IBD) are at higher risk of melanoma, a form of skin cancer, report researchers at Mayo Clinic. Researchers found that IBD is associated with a 37 percent greater risk for the disease. ...

Stage III/IV melanoma patients at risk for new primaries

December 10, 2013

(HealthDay)—Patients with stage III or IV melanoma who have not received treatment with BRAF inhibitors remain at risk for developing new primary melanomas (NPMs), although the incidence rates are lower than those observed ...

Cancer risk up in bilateral retinoblastoma survivors

February 23, 2012

(HealthDay) -- For survivors of bilateral retinoblastoma (Rb), family history is associated with an increased risk of second cancers (SCs), especially melanoma, according to a study published online Feb. 21 in the Journal ...

Recommended for you

Utah man may have contracted Zika from dying father's tears

September 29, 2016

A Utah man who mysteriously contracted Zika from his infected father may have got it by touching his dad's tears or sweat with his bare hands, according to new research unveiled Wednesday that found the unusual transmission ...

Acne sufferers' cells may be protected against aging

September 28, 2016

Scientists at King's College London have found that people who have previously suffered from acne are likely to have longer telomeres (the protective repeated nucleotides found at the end of chromosomes) in their white blood ...

Antibiotics developed in 1960s show promise for TB therapy

September 28, 2016

First generation cephalosporins—antibiotics introduced as a treatment against bacterial infections in 1963—now show promise for tuberculosis (TB) therapy, according to new research published in Scientific Reports.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.